Xerox to Acquire RSA Medical to Bolster its Healthcare-Provider Portfolio
Xerox reports that it’ll be purchasing RSA Medical for an undisclosed sum. It says the acquisition will expand its portfolio of healthcare-service offerings to payers and life insurers using predictive analytics to enhance outreach services aimed at improving overall population health.
RSA Medical is a provider of health-assessment and risk-management for companies that interact with health- and life-insurance companies. Xerox says integrating RSA Medical into its Commercial Healthcare Services business will expand its ability to support healthcare payers, including application and enrollment, operations and claims-management, customer care, and population health-management.
“An estimated 16 million more Americans have health insurance under the Affordable Care Act – many for the first time,” commented Kelly Rakowski, senior vice president of Healthcare Payer Services at Xerox. “With this acquisition, we will help health plans educate new enrollees about services available to them and close gaps in care when necessary. We’ll also provide payers with insights into population health trends, and coordinate timely and personal clinical interventions for at-risk individuals and populations.”
Powered by its proprietary MedGine platform and individualized patient-engagement capabilities, RSA Medical uses population-health focused data analytics that enable health plans to support early identification of medical conditions and other risk factors, increasing payers’ ability to assist their members in maintaining wellness and managing chronic medical conditions.
Xerox works with some of the top nationally managed health plans, 12 of the largest Blue Cross Blue Shield plans, and pharmacy-benefit managers, as well as several local and regional health plans. Through its services, Xerox reaches approximately two-thirds of all insured Americans, including processing more than 1 billion claims annually and handling approximately 50 million interactions with members and providers per year.
The RSA Medical management team and its employees will remain with the company, with Salviola leading operations and reporting to Xerox’s Rakowski.
The acquisition is subject to customary closing conditions and is expected to close in the third quarter of 2015.